|
gptkbp:instanceOf
|
gptkb:company
|
|
gptkbp:acquiredBy
|
gptkb:PWNHealth
|
|
gptkbp:acquisitionYear
|
2021
|
|
gptkbp:category
|
gptkb:biotechnology
health technology company
|
|
gptkbp:CEO
|
gptkb:Othman_Laraki
|
|
gptkbp:focus
|
clinical genetics
COVID-19 response
population genomics
public health infrastructure
|
|
gptkbp:foundedYear
|
2013
|
|
gptkbp:founder
|
gptkb:Elad_Gil
gptkb:Nish_Bhat
gptkb:Othman_Laraki
gptkb:Taylor_Sittler
|
|
gptkbp:fundedBy
|
venture funded
|
|
gptkbp:headquartersLocation
|
gptkb:Burlingame,_California,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Color Genomics
|
|
gptkbp:industry
|
healthcare
genetic testing
|
|
gptkbp:investor
|
gptkb:Emerson_Collective
gptkb:Khosla_Ventures
gptkb:8VC
gptkb:Felicis_Ventures
gptkb:General_Catalyst
gptkb:CRV
|
|
gptkbp:mission
|
democratize access to genetic information
|
|
gptkbp:notableEvent
|
acquired PWNHealth in 2021
expanded into COVID-19 testing in 2020
launched $249 hereditary cancer test in 2015
|
|
gptkbp:notableFor
|
affordable genetic testing
hereditary cancer risk testing
partnerships with health systems
|
|
gptkbp:partner
|
gptkb:NorthShore_University_HealthSystem
gptkb:Alameda_County_Public_Health_Department
gptkb:Mercy_Health
gptkb:NIH_All_of_Us_Research_Program
gptkb:San_Francisco_Department_of_Public_Health
|
|
gptkbp:product
|
COVID-19 testing
genetic testing kits
population health programs
|
|
gptkbp:regulates
|
CAP-accredited
CLIA-certified
|
|
gptkbp:servesArea
|
gptkb:United_States
international
|
|
gptkbp:website
|
https://www.color.com/
|
|
gptkbp:bfsParent
|
gptkb:Elad_Gil
|
|
gptkbp:bfsLayer
|
5
|